AHCC 연구회가 주최하고 일본 홋카이도 경제산업국과 주식회사 아미노업화학이 후원하는  
제24회 통합의료 기능성 식품 국제회의(ICNIM2016)가 개최되었습니다.
통합의료 기능성 식품 국제회의 ICNIM은 매년 일본 삿포로에서 열립니다. AHCC를 필두로
주식회사 아미노업사의 원료를 가지고, 원료의 기능성을 연구, 임상실험을 진행하여
다양한 연구성과, 연구정보를 교환하는 의미 있는 자리입니다.
ICNIM2016은 미국 Memorial Sloan Kettering Cancer Center
Gary Deng 씨의 "암 치료에 영양과 보충제 : 미국의 현상"강연으로 시작되었습니다.
 

이후 약 20건의 일반 강연과 약 30건의 포스터 강연이 진행되었습니다.
 ICNIM2016에서는 여성질환에 대한 발표가 두드러졌습니다.

이번 발표를 통해 여성질환과 AHCC의 관계에 대해 긍정적인 시각을 가질 수 있는 자리였습니다.  
 
 
 
Keynote Lecture

“Nutrition and dietary supplements in cancer care: Current status in the United States”
Gary Deng (Memorial Sloan Kettering Cancer Center, USA)
 
Oral Sessions

“Efficacy of Genistein Combined Polysaccharide (GCP) in preventing postmenopausal osteoporosis”
Tomohiro Shimizu (Hokkaido University, Japan)
“Identification of natural product against fatty liver disease based on the induction of alternative autophagy”
Shigeomi Shimizu (Tokyo Medical and Dental University, Japan)
“The biological activities of Oligonol in diabetes and diet-induced insulin resistance”
Sue-Joan Chang (National Cheng Kung University, Taiwan)
“MicroRNA signature in the chemoprevention of breast cancer by AHCC: Particular role of tumor suppressor miR-335”
Chantal Matar (University of Ottawa, Canada)
“Studying the effect of AHCC on human T cell subsets”
Insoo Kang (Yale University, USA)
“Prevention of cancer and malformation by AHCC and dietary compounds”
Taisei Nomura (National Institutes of Biomedical Innovation, Health and Nutrition, Japan)
“Pilot study to evaluate AHCC 1 gram once daily for the eradication of high-risk HPV infections in women”
Judith A. Smith (The University of Texas Health Science Center at Houston, USA)
“Clinical effects of AHCC on high-risk HPV infection and secretory IgA”
Kensuke Miki (Mima Ladies Clinic, Japan)
“Neuroprotective effect of ETAS on cellular disorder in HT22 hippocampal cells”
Junetsu Ogasawara (Kyorin University, Japan)
“Enzyme-treated Asparagus Extract (ETAS) and its constituents show anti-inflammatory effects in rat hepatocytes”
Mikio Nishizawa (Ritsumeikan University, Japan)
“ETAS uptake can protect renal function against cisplatin nephrotoxicity”
Toshihiko Torigoe (Sapporo Medical University, Japan)
“Comparative efficacy and safety of AHCC and dietary nucleotides versus standard treatment for canine leishmaniosis”
Sergi Segarra (Bioiberica S.A., Spain)
“Use of AHCC in cancer patients – observational study of new association: Nucleotides and AHCC”
Massimo Bonucci (Marconi University, Italy)
“Effects of AHCC on nasopharyngeal symptoms and the autonomic nervous system”
Hideaki Waki (Teikyo Heisei University, Japan)
“Effect of AHCC on reducing cardiovascular events in patients with stable coronary disease”
Massimo Fioranelli (Marconi University, Italy)
“Alleviating effect of AHCC on chemotherapy-related adverse events in patients with unresectable pancreatic ductal adenocarcinoma”
Hiroaki Yanagimoto (Kansai Medical University, Japan)
“Chromium role in metabolic and cardiovascular diseases: A general review of evidence”
Suhad M. Bahijri (King Abdulaziz University, Saudi Arabia)
“Capability of nucleoprotein for scavenging oxygen free radical and its mechanism”
Shigeru Hayashida (Gene Trophology Research Institute, Japan)
“Project of information site for evidence-based Japanese Integrative Medicine (eJIM) by the Ministry of Health, Labour and Welfare”
Satoshi Ohno (Osaka University, Japan)
 
Poster Sessions
 
“Adhesion molecules and related member gene profile in AHCC treated normal human lymphocytes”
Alamelu Sundaresan (Texas Southern University, USA)
“Effect of AHCC on metastatic mammary carcinoma-derived MDA-MB-231 cell proliferation, and EphA2 gene expression that affects the tumor cell growth”
Ryo Sakamoto (Ritsumeikan University, Japan)
“CUB Domain-containing Protein 1 (CDCP1) in pancreatic cancer cells was down-regulated by in vitro treatment with AHCC”
Yasuhiro Kuramitsu (Yamaguchi University, Japan)
“Modification of KCTD12 which is down-regulated in Gemcitabine-resistant pancreatic cancer after treatment of AHCC”
Takao Kitagawa (Yamaguchi University, Japan)
“Induction of cell death in gemcitabine-resistant pancreatic cancer cells by AHCC-treatment in vitro”
Masayuki Tokunaga (Yamaguchi University, Japan)
“Investigation of the influence of AHCC oral administration for gene expression profile in mouse liver using DNA array”
Yohei Fujita (Hokkaido Pharmaceutical University, Japan)
“Effect of AHCC on the in situ and metastasis of nude mice with 4T1-GFP-luc breast cancer cells”
Du Jian (Fujian University of Traditional Chinese Medicine, China)
“Neuroblastoma in children – integrative treatment aids a life: Case report and revue of literature”
Ivano Ferri (Outpatient Oncology – Pain therapy, Italy)
“Atopy cases, and the AHCC confirming its clinical value”
Francisco J. Karkow (Fatima’s Faculty, Brazil)
“AHCC for the treatment of Hashimoto thyroiditis – two cases”
Norbert Szalus (ImmunoMedica Institute, Poland)
“Clinical practice of using AHCC in patients with thyroid nodules”
Zhangentkhan Abylaiuly (Kazakh National University, Kazakhstan)
“Monitoring the effect of immunostimulants in women with proven HPV infection”
Ivan Vetsev (Second Municipal Hospital for Obstetrics and Gynecology, Bulgaria)”
“Effect of Active Hexose Correlated Compound (AHCC) in women receiving adjuvant chemotherapy for breast cancer”
Satoru Iwase (The University of Tokyo, Japan)
“The clinical outcomes of AHCC in advanced pancreatic cancer patients with chemotherapy”
Anarkhuu Bold-Erdene (National Cancer Center of Mongolia, Mongolia)
“Clinical experience of AHCC and High Intensity Focus Ultrasound (HIFU) ablation in advanced hepatocellular carcinoma”
Jirached Suksuperm (Chularat Hospital, Thailand)
“Efficacy and safety of AHCC in Thai cancer patients”
Voravud Narin Angkatavanich (Chulalongkorn University, Thailand)
“Isolation and identification of components of Oligonol”
Takehiro Kashiwagi (Kochi University, Japan)
“Testing the addition of Oligonol to improve cell viability following cryopreservation”
Byron Baron (University of Malta, Malta)
“Effects of Oligonol on high glucose-induced inflammatory responses in THP-1 macrophages”
Yoshimi Kishimoto (Ochanomizu University, Japan)
“Oligonol enhances the expression of human follicle dermal papilla cells FGF-7 and WNT10a mRNA”
Hiroaki Yamazaki (Hokkaido Pharmaceutical University, Japan)
“Prevention predictive analysis of metabolic syndrome and its related disease by Oligonol administration using RNA-seq”
Koji Wakame (Hokkaido Pharmaceutical University, Japan)
“Effect of Oligonol, a low-molecular-weight polyphenol derived from lychee fruit, on experimental reflux esophagitis”
Jeong Sook Noh (Tongmyong University, Korea)
“Oligonol, a low-molecular-weight polyphenol derived from lychee fruit ameliorates apoptotic and proliferative events in the pancreas of streptozotocin-induced diabetic rats via regulation of Bax and PDX-1”
Yu Su Shin (Rural Development Administration, Korea)
“Oligonol promotes glucose uptake by modulating the insulin signaling pathway in insulin-resistant HepG2 cells via inhibiting PTP1B”
Jae Sue Choi (Pukyong National University, Korea)
“Improvement of the oral environment of elderly patients with xerostomia by oral intake of the Oligonol rich candy”
Kazumi Hayama (Teikyo University, Japan)
“Anti-obesity effects of Oligonol in healthy subjects: A double blind, randomized placebo-controlled trial”
Masaki Taga (Wayo Women’s University, Japan)
“Effects of Enzyme-treated Asparagus Extract (ETAS) on thermotolerance and hsp genes expression of the nematode C. elegans”
Tetsuya Okuyama (Ritsumeikan University, Japan)
“Effects of Enzyme-treated Asparagus Extract (ETAS) on stress-loaded cultured keratinocytes”
Tomoko Koda (Tokyo Healthcare University, Japan)
“Suppressive effects of Enzyme-treated Asparagus Extract on hydrogen peroxide-stimulated inflammatory responses in murine L929 skin fibroblasts”
Ken Shirato (Kyorin University, Japan)
“A double-blind randomized controlled trial regarding the safety and efficacy of Enzyme-treated Asparagus Extract intake in healthy human subjects”
Asuka Yasueda (Osaka University, Japan)
“The influence of Enzyme-treated Asparagus Extract (ETAS) on asthenopia”
Kiyoshi Morioka (Kichijoji Morioka Eye Clinic, Japan)
“Evaluation of asparagus extract efficacy in correction of mild and moderate cognitive disorders in patients with chronic cerebrovascular pathology”
Natalia Mikhailichenko (International Medical Center “Nevron”, Russia)
“Constituents in perilla extract inhibit production of nitric oxide in rat hapatocytes (5)”
Yukinobu Ikeya (Daiichi University of Pharmacy, Japan)
“Effects of perilla on lipid metabolism in HepG2 cells”
Emi Saita (Ochanomizu University, Japan)
“The level and structure of glucocylceramide in thinned young muskmelon cultivated in Hokkaido”
Kyoichi Osada (Meiji University, Japan)
“Safflower (Carthamus tinctorius L.) seed protects against cisplatin-induced nephrotoxicity”
Chan Hum Park (Rural Development Administration, Korea)
“Development of universal method for skin stimulus test using epidermal keratinocyte mitochondria as a forefront of sensory system”
Toshihiro Ona (Kyushu University, Japan)